Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-09

Clinical Trial Update: Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant [NA]

View source ↗

Summary

A completed clinical trial evaluating low-dose thymoglobulin to protect kidney function after liver transplantation; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Liver Transplantation | NA | Status: COMPLETED | Results posted: 2018-10-09